Paediatrics Clinical Speciality Lead
Adam Glaser is Professor of Paediatric Oncology and Late Effects at the University of Leeds and Honorary Consultant at Leeds Teaching Hospitals NHS Trust. Until 2013 he was; Clinical Director of the National Cancer Survivor Initiative at the Department of Health, England, Late-effects Lead at the Yorkshire Cancer Network and National Cancer Clinical Lead and Advisor at NHS Improvement.
Professor Glaser has extensive experience of the measurement of health-related quality of life and patient reported outcomes in young people and survivors of cancer. He has researched and published widely in these areas and the late effects of cancer with over 70 peer-reviewed publications.
Professor Glaser was involved in the development of the Cancer PROMS Programme at the Department of Health (2010-13). He has worked with ICHOM, the Harvard based international consortium, developing guidelines for the standardisation of outcome assessment following prostate cancer and ePROMs collection.